Skip to main content
. Author manuscript; available in PMC: 2014 Aug 26.
Published in final edited form as: J Alzheimers Dis. 2013;35(4):789–797. doi: 10.3233/JAD-122308

Figure 3.

Figure 3

Mean change scores for delayed story recall from baseline to month 4, with standard errors of the mean (error bars), by sex, treatment group, and ApoE 4 carriage. Placebo indicates saline condition, Low Dose indicates 20 IU intranasal insulin, High Dose indicates 40 IU intranasal insulin. Note: A higher score represents improvement over time. *Significantly improved over placebo (treatment effect). **Significant treatment×sex×ApoE status interaction, p < 0.01.